Please try another search
WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN)'s AIRSUPRA, an inhaled anti-inflammatory medication, has shown promising results in a Phase IIIb trial by significantly reducing the risk of severe asthma...
By Niklas Pollard and Ludwig Burger STOCKHOLM (Reuters) - U.S. scientists Victor Ambros and Gary Ruvkun won the 2024 Nobel Prize in Medicine for the discovery of microRNA and its crucial role in how...
On Monday, Exact Sciences (NASDAQ:EXAS) stock received a reiterated Buy rating and an $82.00 price target from BTIG. The endorsement follows the recent approval by the FDA of Cologuard Plus, Exact...
There is only one way to rescue America’s faltering economy and that’s the wholesale abandonment of Washington’s reckless spending, and borrowing policies of the last quarter century. These policies...
With the US presidential elections just a few weeks away, we take a look at the economic and social program of the Democratic candidate for the White House. Following the interest rate cut announced...
The healthcare sector could present hidden undervalued opportunities. These stocks may be oversold technically and could be ripe for a rebound. Below, we'll take a look a three such stocks primed for...
Instrument Type
Region
Sector
Industry
Date
Category
Provider